Literature DB >> 3784899

Rheumatoid vasculitis: survival and associated risk factors.

R S Vollertsen, D L Conn, D J Ballard, D M Ilstrup, R E Kazmar, J C Silverfield.   

Abstract

We describe the clinical and laboratory characteristics of 52 patients with rheumatoid vasculitis whose condition was diagnosed at a tertiary care center between 1974 and 1981, and we report their survival and the factors that were associated with decreased survival. The patients with rheumatoid vasculitis had decreased survival in comparison with an age-, sex-, and region-matched general population. Their survival was also decreased in comparison to that of an incidence cohort of community patients with rheumatoid arthritis. In the latter cohort, decreased survival was confined to those patients with classic but not definite rheumatoid arthritis. After partial correction for referral bias, we found no difference in survival between the cohort with rheumatoid vasculitis and the cohort with classic rheumatoid arthritis. We found that the age at diagnosis of rheumatoid vasculitis, the therapeutic decisions before and at diagnosis, and the referral distance were the best predictors of survival. Abnormal urinary sediment and hypergammaglobulinemia also predicted poor survival, but because of a lack of specificity in a small number of clinically abnormal values, we urge a cautious interpretation of their importance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3784899

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  17 in total

Review 1.  Combination chemotherapy in rheumatoid arthritis.

Authors:  P M Brooks; A C Schwarzer
Journal:  Ann Rheum Dis       Date:  1991-07       Impact factor: 19.103

2.  Vasculitis associated with rheumatoid arthritis: a case-control study.

Authors:  Ashima Makol; Cynthia S Crowson; David A Wetter; Olayemi Sokumbi; Eric L Matteson; Kenneth J Warrington
Journal:  Rheumatology (Oxford)       Date:  2014-01-17       Impact factor: 7.580

3.  ICAM-1, E-selectin, and TNF alpha expression in labial salivary glands of patients with rheumatoid vasculitis.

Authors:  R M Flipo; T Cardon; M C Copin; M Vandecandelaere; B Duquesnoy; A Janin
Journal:  Ann Rheum Dis       Date:  1997-01       Impact factor: 19.103

4.  Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study.

Authors:  A E Voskuyl; A H Zwinderman; M L Westedt; J P Vandenbroucke; F C Breedveld; J M Hazes
Journal:  Ann Rheum Dis       Date:  1996-03       Impact factor: 19.103

5.  A case of Churg-Strauss vasculitis complicated by small bowel necrosis.

Authors:  G N Schoretsanitis; D M Wakely; T Maddox; C Wastell
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

6.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

7.  Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.

Authors:  C S Lau; M McLaren; J Hanslip; M Kerr; J J Belch
Journal:  Ann Rheum Dis       Date:  1993-09       Impact factor: 19.103

8.  Labial salivary gland biopsy assessment in rheumatoid vasculitis.

Authors:  R M Flipo; A Janin; E Hachulla; E Houvenagel; A Foulet; T Cardon; A Desbonnet; B Grardel; B Duquesnoy; B Delcambre
Journal:  Ann Rheum Dis       Date:  1994-10       Impact factor: 19.103

Review 9.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

10.  Diagnostic strategy for the assessment of rheumatoid vasculitis.

Authors:  A E Voskuyl; J M W Hazes; A H Zwinderman; E M Paleolog; F J M van der Meer; M R Daha; F C Breedveld
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.